Alerts will be sent to your verified email
Verify Email
MADHAVBAUG
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Vaidya Sane Ayurved Laboratories Limited in India offers specialized treatment for chronic ailments like cardiac disease, diabetes, hypertension, and obesity using a mix of modern technology and traditional Ayurveda practices.
Vaidya Sane Ayur Lab major competitors are Gennex Lab, Medico Remedies, Balaxi Pharma., Trident Lifeline, Ambalal Sarabhai Ent, Lyka Labs, Zim Laboratories.
Market Cap of Vaidya Sane Ayur Lab is ₹307 Crs.
While the median market cap of its peers are ₹336 Crs.
Vaidya Sane Ayur Lab seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | ||||||||||||||||||
| Investor Presentation | Mar | Mar Sep | Mar Sep | |||||||||||||||
| Conference Call | Mar Jun Sep | Jun | ||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
